Nai‐Shun Yao

516 total citations
23 papers, 357 citations indexed

About

Nai‐Shun Yao is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nai‐Shun Yao has authored 23 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nai‐Shun Yao's work include Chronic Lymphocytic Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (3 papers). Nai‐Shun Yao is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (3 papers). Nai‐Shun Yao collaborates with scholars based in Taiwan, United States and France. Nai‐Shun Yao's co-authors include David A. Tice, Jean‐Charles Soria, Marna Williams, Leo Tseng, Steven Coats, Rakesh Dixit, Ping‐Ying Chang, Ming‐Fang Cheng, Herng‐Sheng Lee and Chin‐Sheng Lin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Nai‐Shun Yao

21 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nai‐Shun Yao Taiwan 9 211 122 93 73 47 23 357
T.A. Plunkett United Kingdom 11 350 1.7× 166 1.4× 140 1.5× 69 0.9× 97 2.1× 17 576
Laurenz Vormittag Austria 11 153 0.7× 29 0.2× 95 1.0× 53 0.7× 73 1.6× 22 345
Beaven Rake 2 194 0.9× 99 0.8× 168 1.8× 127 1.7× 79 1.7× 2 413
A Mayer United Kingdom 12 217 1.0× 162 1.3× 154 1.7× 60 0.8× 41 0.9× 16 548
Meltem Baykara Türkiye 12 153 0.7× 30 0.2× 51 0.5× 76 1.0× 118 2.5× 48 349
Fanny Le Du France 10 238 1.1× 49 0.4× 96 1.0× 134 1.8× 174 3.7× 30 491
Shawn Steen United States 11 148 0.7× 44 0.4× 80 0.9× 121 1.7× 45 1.0× 22 334
D. Kardamakis Greece 13 155 0.7× 101 0.8× 100 1.1× 42 0.6× 109 2.3× 26 388
Zhiheng Liang China 8 263 1.2× 56 0.5× 205 2.2× 198 2.7× 132 2.8× 14 693
Le Xiao China 13 193 0.9× 55 0.5× 198 2.1× 176 2.4× 86 1.8× 29 529

Countries citing papers authored by Nai‐Shun Yao

Since Specialization
Citations

This map shows the geographic impact of Nai‐Shun Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nai‐Shun Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nai‐Shun Yao more than expected).

Fields of papers citing papers by Nai‐Shun Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nai‐Shun Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nai‐Shun Yao. The network helps show where Nai‐Shun Yao may publish in the future.

Co-authorship network of co-authors of Nai‐Shun Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Nai‐Shun Yao. A scholar is included among the top collaborators of Nai‐Shun Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nai‐Shun Yao. Nai‐Shun Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Coats, Steven, Marna Williams, Rakesh Dixit, et al.. (2019). Antibody–Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index. Clinical Cancer Research. 25(18). 5441–5448. 222 indexed citations
4.
Kreitman, Robert J., Claire Dearden, Pier Luigi Zinzani, et al.. (2018). Moxetumomab pasudotox in heavily pretreated patients with relapsed/refractory hairy cell leukemia: Results of a pivotal international study.. Journal of Clinical Oncology. 36(15_suppl). 7004–7004. 2 indexed citations
5.
Chia, Yen Lin, Kemal Balic, Nai‐Shun Yao, et al.. (2018). Efficacy and safety of moxetumomab pasudotox (moxe) in adult patients (pts) with relapsed/refractory hairy cell leukemia (HCL) in relation to drug exposure, baseline disease burden, and immunogenicity.. Journal of Clinical Oncology. 36(15_suppl). 7060–7060. 2 indexed citations
6.
Brown, Jennifer R., Paolo Ghia, Jeffrey A. Jones, et al.. (2016). Outcomes of patients with relapsed and refractory chronic lymphocytic leukemia (CLL) who discontinue idelalisib treatment.. Journal of Clinical Oncology. 34(15_suppl). 7531–7531. 2 indexed citations
7.
Soumerai, Jacob D., Jacqueline C. Barrientos, Michael Hallek, et al.. (2016). An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies.. Journal of Clinical Oncology. 34(15_suppl). 7513–7513. 1 indexed citations
8.
Chang, Ping‐Ying, Ming‐Shen Dai, Ching‐Liang Ho, & Nai‐Shun Yao. (2014). Administration of gemcitabine and cisplatin in cancer patients with renal failure under hemodialysis.. PubMed. 18(4). 1058–61. 5 indexed citations
9.
Chang, Ping‐Ying, Ming‐Fang Cheng, Herng‐Sheng Lee, Chung-Bao Hsieh, & Nai‐Shun Yao. (2010). Preliminary Experience of Cetuximab in the Treatment of Advanced-Stage Biliary Tract Cancer. Onkologie. 33(1-2). 11–11. 15 indexed citations
10.
Lin, Te‐Yu, et al.. (2009). Lung Cancer Metastatic to the Masticator Space. Onkologie. 32(6). 349–351.
11.
Yao, Nai‐Shun, et al.. (2009). Mediastinitis and mediastinitis-like symptoms associated with mal-positioning of a Port-A catheter. European Journal of Cancer Care. 18(6). 645–649.
12.
Chen, Jia-Hong, Ping‐Ying Chang, & Nai‐Shun Yao. (2009). Gemcitabine Plus Vinorelbine as an Effective Salvage Chemotherapeutic Regimen in Cisplatin-Refractory Germ Cell Tumor. Southern Medical Journal. 102(5). 546–548. 2 indexed citations
13.
Chang, Ping‐Ying, et al.. (2009). Bone Marrow Necrosis Caused by Metastatic Colon Cancer. Journal of Clinical Oncology. 27(23). e48–e48. 8 indexed citations
14.
Yu, J.-C., et al.. (2008). Preliminary experience with gemcitabine and cisplatin adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma. European Journal of Surgical Oncology. 34(8). 906–910. 22 indexed citations
15.
Chan, De-Chuan, et al.. (2007). Ectopic Hepatocellular Carcinoma of the Diaphragm. Digestive Diseases and Sciences. 52(4). 1118–1120. 13 indexed citations
16.
Hsieh, Chung-Bao, et al.. (2006). Comparison of 11C methionine vs. 18F fluorodeoxyglucose in imaging extrahepatic hepatocellular carcinomas: Preliminary results. 47. 1 indexed citations
17.
Lee, Shang‐Sen, et al.. (2006). Production of Beta‐HCG by Spermatic Cord Leiomyosarcoma: A Paraneoplastic Syndrome?. Journal of Andrology. 27(5). 643–644. 8 indexed citations
18.
Yao, Nai‐Shun, et al.. (2006). A phase II study of gemcitabine and liposomal doxorubicin (Lipo-Dox) as first line chemotherapy in the treatment of metastatic breast cancer. Journal of Clinical Oncology. 24(18_suppl). 10688–10688. 1 indexed citations
19.
Cheng, Chih-Jen & Nai‐Shun Yao. (2005). Isolated temporal bone metastasis in a patient with non-small cell lung cancer. European Journal of Radiology Extra. 55(3). 75–77. 4 indexed citations
20.
Yao, Nai‐Shun, et al.. (1999). Lung cancer mimicking acute myocardial infarction on electrocardiogram. The American Journal of Emergency Medicine. 17(1). 86–88. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T.A. Plunkett Breakdown of academic impact, for papers by Laurenz Vormittag Breakdown of academic impact, for papers by Beaven Rake Breakdown of academic impact, for papers by A Mayer Breakdown of academic impact, for papers by Meltem Baykara Breakdown of academic impact, for papers by Fanny Le Du Breakdown of academic impact, for papers by Shawn Steen Breakdown of academic impact, for papers by D. Kardamakis Breakdown of academic impact, for papers by Zhiheng Liang Breakdown of academic impact, for papers by Le Xiao
Rankless by CCL
2026